Cytosorbents (CTSO) Price to Book (2010 - 2026)

Cytosorbents (CTSO) has reported Price to Book for 17 consecutive years, with 1.55 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 547.6% year-over-year to 1.55; the trailing twelve-month figure through Jun 2026 stood at 1.55 (down 547.6% YoY), and the FY2025 full-year result was 0.34, up 51.58% from the prior year.
• Price to Book slipped to 1.55 in Q2 2026 per CTSO's latest filing, from 0.81 in the prior quarter.
• Across five years, Price to Book topped out at 0.81 in Q1 2026 and bottomed at 1.55 in Q2 2026.
• Historically, Price to Book has averaged 0.14 across 5 years, with a median of 0.22 in 2023.
• The widest YoY moves for Price to Book: up 279.08% in 2026, down 547.6% in 2026.
• Over 5 years, Price to Book stood at 0.1 in 2022, then gained by 10.42% to 0.11 in 2023, then soared by 112.79% to 0.22 in 2024, then jumped by 51.58% to 0.34 in 2025, then tumbled by 554.7% to 1.55 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 1.55, 0.81, and 0.34 for Q2 2026, Q1 2026, and Q4 2025 respectively.